GoldenEye_6 (@GoldenEye_6) header
GoldenEye_6 (@GoldenEye_6) profile picture

Disclaimer: Views are personal. Msgs on stock prices or indices are my views and shud not to be construed in any way for trade execution. Advocate By Profession

NISMCertified Research Analyst
Joined December 2018
Photo by GoldenEye_6 (@GoldenEye_6)Photo by GoldenEye_6 (@GoldenEye_6)Photo by GoldenEye_6 (@GoldenEye_6)Photo by GoldenEye_6 (@GoldenEye_6)Photo by GoldenEye_6 (@GoldenEye_6)Photo by GoldenEye_6 (@GoldenEye_6)Photo by GoldenEye_6 (@GoldenEye_6)
📈 INVESTING IS NOT JUST ABOUT WHAT TO BUY, BUT ALSO WHAT NOT TO BUY! My mentorship program is strictly by invitation only. 🚀 I invite investors who have the willingness to learn, an open mind, and the courage to challenge their own beliefs. ✅ No blind following. ✅ No shortcuts to wealth. ✅ Learn what to buy — and more importantly, what to AVOID. ✅ Build discipline, conviction & a long-term mindset. And yes, I charge for mentorship! Because quality knowledge, time, and experience have value. Remember: Free things are often taken for granted. And when a product is free, ask yourself — are you the customer, or the product? Serious investors who value learning over tips are welcome to connect. 🤝 #Investing #StockMarket #FinancialLiteracy #InvestorEducation
28
6
1
79
12,751
🔥 2 HOURS OF NONSTOP TELEGRAM LIVE! 🔥 An exclusive live session for our subscribers! 📊 Market insights | Stock analysis | Investment strategies | Live discussions | Q&A Two hours of uninterrupted knowledge sharing, actionable insights and meaningful discussions. Because serious investors deserve serious conversations! Only for our subscribers. 🚀
4
4
67
2,354
GoldenEye_6 retweeted
2018. An amazing heart warming memory. Spent a few hours with an ex marine veteran. Still fresh and imprinted in my mind. Minnesota. USA.
3
1
19
521
US Stock list is ready for investments !
📈 INVESTING IS NOT JUST ABOUT WHAT TO BUY, BUT ALSO WHAT NOT TO BUY! My mentorship program is strictly by invitation only. 🚀 I invite investors who have the willingness to learn, an open mind, and the courage to challenge their own beliefs. ✅ No blind following. ✅ No shortcuts to wealth. ✅ Learn what to buy — and more importantly, what to AVOID. ✅ Build discipline, conviction & a long-term mindset. And yes, I charge for mentorship! Because quality knowledge, time, and experience have value. Remember: Free things are often taken for granted. And when a product is free, ask yourself — are you the customer, or the product? Serious investors who value learning over tips are welcome to connect. 🤝 #Investing #StockMarket #FinancialLiteracy #InvestorEducation
3
2
49
2,310
ऐसी कंपनी से तो #vodaphoneIdea और #yesbank अच्छी हैं, क्या बात करते हो जैन साहब ! #Investment_is_an_art
5
1
43
4,440
Why I should suffer alone !
63
57
8
342
40,548
GoldenEye_6 retweeted
Intraday traders since October 3rd week. Courtesy:- Everyday gap up
2
2
39
2,181
Minting Money is into “SmallCaps” Join to know more !
📈 INVESTING IS NOT JUST ABOUT WHAT TO BUY, BUT ALSO WHAT NOT TO BUY! My mentorship program is strictly by invitation only. 🚀 I invite investors who have the willingness to learn, an open mind, and the courage to challenge their own beliefs. ✅ No blind following. ✅ No shortcuts to wealth. ✅ Learn what to buy — and more importantly, what to AVOID. ✅ Build discipline, conviction & a long-term mindset. And yes, I charge for mentorship! Because quality knowledge, time, and experience have value. Remember: Free things are often taken for granted. And when a product is free, ask yourself — are you the customer, or the product? Serious investors who value learning over tips are welcome to connect. 🤝 #Investing #StockMarket #FinancialLiteracy #InvestorEducation
3
3
49
3,220
GoldenEye_6 retweeted
Revisiting my early memories of celebrating Diwali - the traditions, the festivities and the little moments that made it so special 🪔✨ Wishing everyone a Happy Diwali
889
4,520
164
19,442
560,115
GoldenEye_6 retweeted
#Nifty We witnessed a massive weekly bar last week, with a bullish closing of 8.58% and a weekly bar spanning a range of 7.86%. The last time we witnessed such an expansive weekly range was during the 2024 election result week, when the bar spanned 9.67% from low to high. Since 2024, the 24500-25000 zone has acted as a pivotal price range, having been tested more than 10 times by price over the past two years. On February 27th, price registered a low of 24141.3, and the subsequent trading session witnessed a 2% gap-down. Price attempted to fill this gap intraday but failed to breach the psychological 25000 barrier. This gap left at 25141.3 will most likely get filled during the Muhurat session or sometime in the coming week. Psychologically, everyone is overwhelmingly bullish right now, and rightly so. Nifty witnessed a spectacular rally last week, even though the broader market did not participate in the move to the same extent. Market sentiment often fuels FOMO, and we retail traders have an unfortunate tendency to go all in at the tops and bottoms. Then, when the market starts moving against us, we find ourselves trapped, desperately hoping and praying for a breakeven exit while the market relentlessly denies us that opportunity. What should you do if you missed the rally? Nothing. Wait patiently for a retracement and look for signs of continuation in price action. If someone tells you they captured the entire Nifty rally, congratulate them and move on. The probability of any retail trader capturing the entire rally amid such massive gap-ups and sustained upside momentum is exceptionally slim. Most traders, much like us, would have captured only smaller portions of the move through intraday scalps. If you come across people boasting about capturing a massive move, simply ignore the noise. If you missed the rally, chances are that the overwhelming majority did too. Another extremely important factor to remain mindful of at this juncture is recency bias. Do not allow yourself to be carried away by the magnitude of the recent move. Yes, it happened, and someday in the future, we might witness something equally extraordinary again. But remember the fundamental nature of price movement. Approximately 80% of the time, price moves gradually within ranges, while the remaining 20% witnesses explosive, parabolic moves. So keep your wits about you and do not succumb to FOMO. Now, coming to the short-term technical structure of Nifty. The immediate intraday support zone lies between 24512-24675. If price manages to defend this zone, a higher high (HH) above 24.95k becomes a likely possibility. However, if this zone gives way, the 23884-24279 region emerges as the next major support zone, potentially providing a cushion against any further pullback in price. Therefore, watch for signs of pullback reversals within this zone on higher timeframes, such as the 75m or 4h charts, and allow price action to guide your decisions. If, by chance, price breaches 23870 and sustains below 23800, the subsequent downside liquidity levels are positioned at 23550, 23300, 22995, and 22355. Right now, it probably feels as though price will never decline again and Nifty will simply continue its relentless ascent towards 30k, doesn't it? But cast your mind back to August-September. You might have experienced the exact opposite sentiment, convinced that price would keep falling indefinitely and that Nifty would not find a bottom before 20k. This is precisely why the best approach is to maintain an open mind and allow price action to guide us rather than letting our emotions dictate our decisions. Overconfidence is perhaps one of the traits that the market punishes most mercilessly. Let's remain humble this Diwali and acknowledge that the market will only reward us in proportion to the effort, discipline, and dedication we invest in understanding it. There are a thousand things to learn from the markets every single day. Focus on the process, not the destination, and the eventual outcome might very well turn out to be extraordinary. Happy Diwali!
14
11
3
129
16,889
Hello X Support Team, account @KdSimplyAmple was suspended. He have always followed X’s Community Guidelines and Rules. I believe this suspension was made in error. He do not engage in spam, abuse, harassment, or any prohibited activity. This is genuine personal account that he manage manually. Kindly review his account and reactivate it at the earliest. He is happy to provide any additional information if needed. Thank you. @X @XCorpIndia
4
6
16
2,751
GoldenEye_6 retweeted
Doctors: This lacks clinical validation and does nothing. Deepinder: 'Ah, but it comes in Purple Funk and True Gold'. The research paper is my bank statement. Now go buy a samosa on Zomato.
This is who Deepinder is dissing...real doctors. Suniye zara doctors kya kah rahe hain...
2
3
26
1,594
🤣🤣🤣🤣
Replying to @deepigoyal
Deepinder goyal since yesterday:- teja main hoon temple idhar hai
3
29
1,787
He is the new mayor of Gujarat States Capital City Gandhinagar !
135
201
43
1,665
220,555
❤️💚
Your parents won't see you grow old. Your partner never knew you as a child, and your children won't remember you young. You are the only person who witnesses every version of yourself. Take care of yourself, value yourself and love yourself. You are your lifelong companion.
1
2
17
2,600
Show me the man, and I'll show you the rule! That's the situation everywhere. Nothing has changed before or after 2014.
3
45
3,095
GoldenEye_6 retweeted
Healthfrauds, I will skip your AI generated slop response and come straight to the points raised on so-called P32 Wellness nonsense founded by celebrity cricketer, Yuvraj Sigh. Wear your helmets and seat belts. This will feel like an educational crash and thrashing, because you cons deserve it. Your statement - “Dr Philips, we will skip the insults and answer the science.” Oh really? You want to skip what was deserving for you health con and want to address the imaginary? Sure, I can play this game. Lets science. Your statement – “Unlike your argument, Protocol32 is NOT for anyone with cancer, we NEVER claimed it. It is for healthy adults, especially vegetarians who run short on B12, DHA and creatine.” So why is your product not just B12, DHA and creatine? But a mumbo jumbo mix of more than 30 other components? The other responses you made are like farts in a wind tunnel, they are just critiques of the paper I posted, which means you have no clue about the papers I did not post on the same topic. This is a shoddy way to do healthcare business. But then let me address few other really wonderfully ignorant and health illiteracy proving statements of yours below. Your statement – “Liver NIH LiverTox rates bacopa and boswellia E, unlikely to cause liver injury. Curcumin and ashwagandha carry a real but very rare risk. Our booklet says so in print, and members get ALT and GGT tested on day 1 and day 90, for subscribers its paid by us. You say 13 of our ingredients carry toxicity risks. Name them, with the dose at which each harm was found, and we will answer each one in public.” This must be your best-worst proof that you all do “science”. You should have taken the insult, taken the L and stopped doing more harm to your product which was already dead to begin with for “whatever wellness”. The herbs cited carry risks, some risks are larger and known, some smaller – category E (as you mentioned) – unlikely to cause liver injury – BECAUSE THOSE WERE THE ONLY ONES REPORTED AND PUBLISHED THERE IN THE USA (see Bacopa series in India and new ones being reported) – this does not confirm that the botanical is safe on its own, or that it is safe when used together with other botanicals! Herb-induced injury is idiosyncratic (meaning no dose or duration is required and liver toxicity can happen in few hours to few days and even after years of use). You do not even know this basic and is calling me out on “name them, with the dose at which each harm was found, and we will answer each one in public” – man you guys are really dumb and you are selling a health product? GET OUT OF HERE. Child, or whoever non-medical is trying to respond to me on science on Twitter, you should have been aware of the fact that multiple botanicals in the same product increases risk of organ toxicity. Take the example of curcumin and green tea. Damage with curcumin + green tea is far worse for the person than either alone (medscape.com/viewarticle/tur…)... ...and you have more than 8 active herbal/botanical extracts; or 11 if also counting the 2 plant-derived carriers in your product AND is going to be the most dangerous wellness product in the Indian market right now. You have ZERO data to disprove my points. You statement – “Protocol32 is taken every day for years, while most of these trials ran for weeks or months, so we set maintenance amounts, not treatment doses. We do not claim a trial result at a dose the trial did not test. Every one of the 32 ingredients is on the FSSAI permitted list, within its FSSAI limit.” You have ZERO trials ongoing, done or published to showcase the benefits or objectify the actual harm from this product. FSSAI’s limit does not mean it is a safe limit that can be used on people at population scale. FSSAI will give a stamp & seal in any case because it is Yuvraj’s face on the product and only looks at good manufacturing pracitces - their approval is for a clean factory, not what the product can do to people. Dont be so naiive. Do you think the scientific and public community in India are that stupid? You think you can do this and get away with the con? Your statement – “Many brands hide their doses in a proprietary blend. We print every dose, form and specification, and even what the raw material costs us. We did that so any doctor could check our work and question it. We welcome that. A clinical trial of Protocol32 is under way, and we will publish the results, whatever they show. Some of your points are fair. Where we can do better, we will.” So basically, you have no idea about what your product does. Protocol 32 does not have a public Clinical Trials Registry - India (CTRI) registration lookup ID, but your product is already commercially available through paid endorsement and invitation. You want to do better? STOP LYING. There is no clinical trial underway - it had to be a prospective trial and HAS TO BE registered, which right now, seems to be hiding behind the bushes on the internet. Care to show us the proof of registration? You want to really do better? Throw the damn product off your shelves and give that money to help the Government build better roads, provide better facilities in public transports, build bridges that will connect underserved communities to basic healthcare, promote meal programs in school to help children fight protein malnutrition, and help clean our rivers. Idiots.
Replying to @theliverdoc
Dr Philips, we will skip the insults and answer the science. Unlike your argument, Protocol32 is NOT for anyone with cancer, we NEVER claimed it. It is for healthy adults, especially vegetarians who run short on B12, DHA and creatine. Our answers are below, with the source links in the four images. --- IMAGE 1: Cancer We agree with the study you linked. Johnson et al. in JAMA Oncology 2018 found that the extra deaths came from patients refusing or delaying standard treatment. No supplement should ever replace cancer treatment, and anyone on any medicine should show their doctor our label first. The cancer paper you linked flags B6, B12, zinc and vitamin E only at many times our dose. It does not discuss NAC, vitamin C or astaxanthin. Yuvraj beat cancer with chemotherapy. Since 2012 his foundation, YouWeCan, has screened over 1.4 lakh people for cancer and paid for hospital treatment for children whose families could not afford it. --- IMAGE 2: Liver NIH LiverTox rates bacopa and boswellia E, unlikely to cause liver injury. Curcumin and ashwagandha carry a real but very rare risk. Our booklet says so in print, and members get ALT and GGT tested on day 1 and day 90, for subscribers its paid by us. You say 13 of our ingredients carry toxicity risks. Name them, with the dose at which each harm was found, and we will answer each one in public. --- IMAGE 3/4: Evidence behind all 32 19 have a randomised controlled trial behind them, 6 a pooled analysis of trials, and 1 a controlled feeding study. 6 have no trial at our dose, and we say so. Nine sit at or near their trial dose. The rest are lower on purpose. Protocol32 is taken every day for years, while most of these trials ran for weeks or months, so we set maintenance amounts, not treatment doses. We do not claim a trial result at a dose the trial did not test. Every one of the 32 ingridents is on the FSSAI permitted list, within its FSSAI limit. --- Why We Publish Everything Many brands hide their doses in a proprietary blend. We print every dose, form and specification, and even what the raw material costs us. We did that so any doctor could check our work and question it. We welcome that. A clinical trial of Protocol32 is under way, and we will publish the results, whatever they show. Some of your points are fair. Where we can do better, we will. Everything is at protocol32.com
58
410
12
2,653
138,954